OSE Immunotherapeutics S.A.

OSE.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€15-€20€57-€11
Dep. & Amort.€2€0€2€2
Deferred Tax€0€0€0€0
Stock-Based Comp.€0€0€0€0
Change in WC-€3-€6€8€0
Other Non-Cash-€2€7€0€1
Operating Cash Flow-€18-€18€67-€8
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0-€0
Inv. Purchases-€0-€47-€0-€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€30€55-€55-€0
Investing Cash Flow€30€8-€55-€1
Financing Activities
Debt Repay.-€3€1-€4€1
Stock Issued€0€1€0€11
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0-€0-€0-€0
Financing Cash Flow-€4€2-€5€12
Forex Effect€0-€50€50-€0
Net Chg. in Cash€9-€59€57€4
Supplemental Information
Beg. Cash€17€76€19€15
End Cash€25€17€76€19
Free Cash Flow-€18-€18€67-€8
OSE Immunotherapeutics S.A. (OSE.PA) Financial Statements & Key Stats | AlphaPilot